2. Vodafone mHealth Solutions 3
Vodafone mHealth Solutions Insights Guide
Welcome
!"#$%&"'(%'%)*'+*,('-".#(/'0"1.("'2)1#3$.(3%4'5'(/"'
64,37/(,'8)39":';)*'.3&'3,'(%'2*%<39"',%&"'"<39"4$"=
1.,"9',(3&)#),'(/.('>3##'"4$%)*.7"'.##'(/%,"'>%*?347'
in the different areas of healthcare to consider the
344%<.(3%4'%22%*()43(3",'(/.('.*"'4%>'.<.3#.1#"'(%'(/"&:'
!"'1"#3"<"'(/.('*".#'2*%7*",,'$.4'%4#@'1"'343(3.("9'>/"4'
.##',(.?"/%#9"*,'#%%?'1"@%49'(*.93(3%4.#'/%*3A%4,'.49'
share ideas that challenge the status quo so that together
>"'$.4'39"4(3B@'4">'>.@,'%B'.99*",,347'$)**"4('3,,)",:'
C/"'%2343%4,'"D2*",,"9'34'(/3,'
9%$)&"4('.*"'4%('%)*,'1)('(/"@'.*"'
(/%,"'%B'349"2"49"4('"D2"*(,'>/%,"'
<3">,'>"'*",2"$('5'"<"4'3B'>"'9%4E('
.#>.@,'.7*""'>3(/'(/"&:'6'(/.4?'
(/"&'B%*'(/"'(3&"'.49'"BB%*('(/"@'
/.<"'34<",("9'34'"D2#%*347'(/3,'(%23$:'
6'1"#3"<"'(/"@'/.<"'3&2%*(.4('(/347,'
(%',.@'(/.(',/%)#9'1"'%B'34("*",('(%'
.4@%4"'$%4$"*4"9'>3(/'(/"'#%47=("*&'
B)()*"'%B'(/"'/".#(/$.*"'349),(*@:
!"'/%2"'(/3,'9%$)&"4('$.4'%BB"*'@%)'
,%&"'34,37/(,'(/.('>3##'2*%<39"'(/"'
3&2"(),'(%'7"4"*.("'2%,3(3<"'$/.47":'
6('3,'(/"'+*,('%B'.',"*3",'.49'>"'#%%?'
B%*>.*9'(%'/".*347'@%)*'*",2%4,"'(%'
our ideas in the months to come.
FD"#'G"&"(A
Head of Vodafone mHealth Solutions
C/"'H%9.B%4"'-".#(/'0"1.("',"*3",'3,'2.*('%B'%)*'$%4(34)347'$%&&3(&"4('
(%'(/%)7/('#".9"*,/32'34'/".#(/$.*":'6('1*347,'(%7"(/"*',"43%*'2/.*&.I'2)1#3$'
.49'2*3<.("'/".#(/',(.?"/%#9"*,'(%'#".*4I',/.*"'.49'9"1.("'%4'3,,)",'.49'4">'
(/34?347'1*%)7/('B%*>.*9'1@'*"4%>4"9'(/%)7/('#".9"*,'.49'349),(*@'"D2"*(,:
4. Vodafone mHealth Solutions 5
Vodafone mHealth Solutions Insights Guide
Scope and !"#$%&%'$(
N''&-".#(/L'.22#3$.(3%4'%B'&%13#"'.49'
4"(>%*?'("$/4%#%73",'(%'3&2*%<"'
/".#(/$.*"'%)($%&",'%*'"B+$3"4$3",O'
P%*'(/"',$%2"'%B'(/3,'*"2%*(I'>"'
B%$),'%4'2.(3"4('.49'/".#(/$.*"'
2*%B",,3%4.#'$"4(*"9'&-".#(/',"*<3$",'
including remote care and healthcare
2*%B",,3%4.#'&%13#3,.(3%4
N''&-".#(/',"*<3$",L'34$#)9",'.4@',%B(>.*"I'
/.*9>.*"I'.49',"*<3$",'*"Q)3*"9'(%'&.?"'
(/"'"49=(%="49'&-".#(/',%#)(3%4
N''R.(3"4(,L'34$#)9",'1%(/'$%4,)&"*,'
3:":'S/".#(/@T'3493<39).#,I'.49'2"%2#"'
>3(/'.'#%47'("*&'%*'.$)("'$%493(3%4'
N''-UR,L'/".#(/$.*"'2*%B",,3%4.#,'34$#)9347'
4)*,",I'2*3&.*@'.49',"$%49.*@'$.*"'
9%$(%*,I',2"$3.#3,(,I'.49'2/.*&.$3,(,:'
C/"'7)39"'>3##'B%$),'%4'1"/.<3%)*,'>3(/34'(/"'&.()*"'
&.*?"(,'.49'&.34(.34'(/"'B%##%>347'9"+43(3%4,'(/*%)7/%)('
(/"'*"2%*(L
5. Vodafone mHealth Solutions 6
Vodafone mHealth Solutions Insights Guide
What patients and
healthcare professionals say
V",)#(,',/%>'.'7"4)34"'34("*",('34'),347'
&%13#"'("$/4%#%7@'(%'3&2*%<"'2.(3"4('$.*"'
.49'34$*".,"'"B+$3"4$3",:'-%>"<"*'<"*@'
*".#'$%4$"*4,'"D3,('.*%)49'3(,'*"#3.13#3(@I'(/"'
$%,('%B'3&2#"&"4(.(3%4'.49'(/"'.13#3(@'%B'
2.(3"4(,'(%'),"'3(:'C/"'B%##%>347'$%&&"4(,'
.*"'34$#)9"9'34'(/3,'*"2%*('(%'73<"'(/"'*".9"*'
.4'3493$.(3%4'%B'(/"'*",2%4,",'>"'*"$"3<"9'
%4',2"$3+$'(%23$,:'
W"B%*"'.4.#@,347'(/"'$/.47347'.((3()9",'(%>.*9,'
&-".#(/'343(3.(3<",I'H%9.B%4"'$%&&3,,3%4"9'*",".*$/1
34'%*9"*'(%'1"(("*')49"*,(.49'(/"'$)**"4('.22*%.$/'(%'
/".#(/$.*"'9"#3<"*@'.&%47,('/".#(/$.*"'2*%B",,3%4.#,'
.49'(/"3*'2.(3"4(,:'
Stakeholder Group What they want from mHealth
Specialists C%'/"#2'&.4.7"'9.(.'.49'&.?"'(/"'1",('),"'%B'("$/4%#%7@
GPs C%'"&2%>"*'(/"3*'2.(3"4(,'.49'/"#2'(/"&'&.4.7"'$/*%43$'
diseases
Nurses C%'.$$",,'34,(*)$(3%4.#'34B%*&.(3%4'%*'2.(3"4('9"(.3#,'%4=(/"=7%
Pharmacists C%'/"#2'(/"&'&.4.7"'2.(3"4('2*",$*32(3%4,I'"4,)*"'.$$)*.$@'
.49'/"#2'>3(/'2.(3"4('$%&2#3.4$"
Patients C%'1"(("*'&.4.7"'.49'(*.$?'(/"3*'3##4",,",
Table 1 What HCPs and Patients say
What patients have to say
R.(3"4(,'$.4',""'(/"'1"4"+('%B'&-".#(/'
1"$.),"'3&2*%<"9'.$$",,'(%'34B%*&.(3%4'
"4.1#",'(/"&'(%'1"$%&"'&%*"'.$(3<"#@'
34<%#<"9'34'(/"3*'%>4'$.*":'C/3,'3,'
2.*(3$)#.*#@'(*)"'B%*'(/%,"'>3(/'$/*%43$'
$%493(3%4,',)$/'.,'93.1"(",'%*'/37/'1#%%9'
2*",,)*":'X%13#"'("$/4%#%7@'$.4'/"#2'
them to monitor their condition outside
.'/%,23(.#'"4<3*%4&"4(:'6('&".4,'&%*"'
2"%2#"'$.4'"4Y%@'.'4%*&.#'#3B"'1)('$.4'
*".$(',>3B(#@'(%'*"$"3<"'(*".(&"4(',/%)#9'
the need arise.
6. Vodafone mHealth Solutions 7
Vodafone mHealth Solutions Insights Guide
What healthcare professionals
have to say
C/"'&.Y%*3(@'%B'/".#(/$.*"'2*%B",,3%4.#,',""'
(/"'.9<.4(.7",'%B'&-".#(/'1)('>3(/34'(/"'
,"$(%*'93BB"*"4('"&2/.,3,'3,'73<"4'(%'93BB"*"4('
"#"&"4(,:'P%*'"D.&2#"I'4)*,",'.49'8R,'.*"'
&%,('$%4$"*4"9'>3(/'3&2*%<347'2.(3"4('
$%&2#3.4$":'8R,'.#,%',""'(/.('&-".#(/'
("$/4%#%7@'$.4'*"9)$"')44"$",,.*@'2.(3"4('
<3,3(,'.49'(/"*"B%*"'$)('$%,(,:'G)*,",'%4'(/"'
%(/"*'/.49'1"#3"<"'(/.('&-".#(/'343(3.(3<",'
&.@'>"##'*"9)$"'.9&343,(*.(3%4'(3&"I'>/3$/'
>3##'34'()*4'.##%>'(/"&'(%',2"49'&%*"'(3&"'
$.*347'B%*'(/"3*'2.(3"4(,:''P34.##@',2"$3.#3,(,'
.49'2/.*&.$3,(,'1"#3"<"'(/.('&-".#(/'
,%#)(3%4,'$.4'3&2*%<"'$%&&)43$.(3%4'
>3(/'8R,',%'(/.('(/"@'$.4',/.*"'93.74%,3,'
.49'#".*4347E,'&%*"'"BB"$(3<"#@:
-"*"'3,'>/.('(/"@'/.<"'(%',.@L'
0",23("'(/3,'"4(/),3.,&'&-".#(/'.9%2(3%4'/.,'4%('1""4',$.#"9'.,'&)$/'
.,'%4"'>%)#9'/.<"'"D2"$("9:'J)1,"Q)"4('"93(3%4,'%B'(/"'H%9.B%4"'64,37/(,'
8)39"'>3##'"D2#%*"'%(/"*'*".,%4,'B%*'(/3,'34'&%*"'9"(.3#'1)('/"*"I'34'(/"'+*,('
%B'(/"',"*3",I'>"'>3##'B%$),'%4'>/.(',%&"'>%)#9'.*7)"'3,'(/"'&.34'1.**3"*'(%'
(.?"')2'5'/)&.4'1"/.<3%)*:'
Improving quality of life
ZFB("*'6'+*,('/.9'&@'+*,('/".*('.((.$?'
B%*'(/"'(/*""'>""?,'1"(>""4'(/"'+*,('
%4"'.49'(/"',"$%49'%4"'6'/.9'(%'(.?"'
&@'1#%%9'2*",,)*"'/.#B'.'9%A"4'(3&",'
.'9.@'.('(/"'9%$(%*E,'%B+$"I'.49'6'$%)#9'
/.<"'Y),('),"9'&@'2/%4"'(%'*"$%*9'3('.('
/%&"'34,(".9E'
U.*93.$'R.(3"4(I'M['
Reassurance
Z64'&@'/%,23(.#'7*%)2I'>"'7"('34'(%)$/'
%<"*'(/"'64("*4"(:'C/"*"E,',%&"%4"'(/"*"'
(%'.4,>"*'@%)*'Q)",(3%4,']'/%)*,'.'9.@I'
either a doctor or a nutritionist. I can do
3('B*%&'/%&"'%*'>%*?I'.49'3('73<",'&"'
2".$"'%B'&349:E'
03.1"(3$'R.(3"4(I'J2.34
Discretion
Z6'9%4E('>.4('%(/"*'2"%2#"'(%'B""#',%**@'
B%*'&"'1"$.),"'6E&'.'93.1"(3$I',%'6'9%4E('
>.4(I'3B'6'(.?"'%)('.'$"##'2/%4"I'"<"*@%4"'
(%'?4%>'Z%/I'(/"'2%%*'7)@'3,'.'93.1"(3$:E'
03.1"(3$'R.(3"4(I'J%)(/'FB*3$.
Caring for patients
Z6('>%)#9'1"'43$"'(%'1"',.('>3(/'(/"'
2.(3"4('.49'/.<"'.'2/%4"'(%'*"73,("*'
>/.('@%)E*"'9%347I'>/.('@%)E<"'9%4"I'
and have that recorded and logged.
6(',/%)#94E('1"'.'4)*,347'Y%1I',/%)#9'3(^
'6('(.?",'.1%)('(>%'/%)*,'.'9.@'
>*3(347'(/"'4%(",:E
G)*,"I'M[:
Improved communication
between professionals
Z&-".#(/'>3##'1"'.4'.99"9'<.#)"'1"$.),"'
(/"'7"4"*.#'2*.$(3(3%4"*'>3##'#".*4'.1%)('
93BB"*"4('2.(/%#%73",'1@'*"$"3<347'
34B%*&.(3%4'B*%&'(/"',2"$3.#3,"9'9%$(%*:E'
J2"$3.#3,(I'J2.34
C/"'B%##%>347'Q)%(.(3%4,'.*"'"D.&2#",'%B'(/"'&.34'1"4"+(,'>/3$/'>"*"'/37/#37/("9:
7. Vodafone mHealth Solutions 8
Vodafone mHealth Solutions Insights Guide
An overview of
mHealth opportunity
C/"'&-".#(/'&.*?"('3,',(3##'<"*@'@%)47'
/%>"<"*'3('3,'$#".*'(/.('(/"'%22%*()43(@'B%*'
("$/4%#%7@'9*3<"4'/".#(/$.*"'3,'(/*3<347'
as a result of a changing healthcare
"4<3*%4&"4(:'V"&%("I'34("##37"4('
&%43(%*347'.49'93.74%,3,'B%*'"D.&2#"I'/.,'
(/"'2%("4(3.#'(%'"4/.4$"'Q).#3(@'%B'#3B"I'
3&2*%<"'/".#(/$.*"'"B+$3"4$@'.49'%BB,"('
1)*7"%4347'/".#(/$.*"'$%,(,'B*%&'.'7*%>347I'
.7"347'.49'34$*".,347#@'%1","'2%2)#.(3%4:
64'.'>.@I'>"'.*"'<3$(3&,'%B'%)*'%>4',)$$",,'
.49'1@'*"9)$347'(/"'$.),",'%B'9".(/'&.4@'
&%*"'2"%2#"'.*"'4%>'#3<347'34(%'.7"'1.49,'
(/"'>%*#9'/.,4E('"D2"*3"4$"9'1"B%*"'5'>/"*"'
(/"@'4""9'&%*"'$.*"'5'.49'&%*"'"D2"4,3<"'
$.*":'-".#(/$.*"',"*<3$",'.*%)49'(/"'>%*#9'
.*"'(/"*"B%*"')49"*'2*",,)*"'(%'34$*".,"'(/"'
Q).#3(@'%B'$.*"'(%'2.(3"4(,'.('.'(3&"'>/"4'
(/"'7#%1.#'2%2)#.(3%4'3,'.7347I'(/"'1)*9"4'
of chronic disease is rising and the economic
$%493(3%4,'.*"'$/.##"47347:'64'K)*%2"I'B%*'
"D.&2#"I'(/"'%<"*=_`,I'>/%,"'/".#(/$.*"'
$%,('1)*9"4'3,'B%)*'(3&",'(/.('%B'@%)47"*'
.7",I'>3##'.$$%)4('B%*'.('#".,('`a'%B'
(/"'2%2)#.(3%4'1@'b]b
:'F#%47,39"'(/3,I'
)4/".#(/@'#3B",(@#"'$/%3$",',)$/'.,'
,&%?347'.49'2%%*'93"(I'(/"'34$*".,347'*3,?'
%B'.49'$%4$"*4'.*%)49'(/"'2%("4(3.#'3&2.$('
%B'2.49"&3$'93,".,",I'(/"'#3&3("9'4)&1"*'
.49')4"<"4'93,(*31)(3%4'%B'/".#(/$.*"'
>%*?"*,I'2%%*'9*)7'93,(*31)(3%4'.49'(/"'
#"47(/@'9"<"#%2&"4('$@$#",'%B'4">'
&"93$34",'.*"'$%&134347'(%'&.?"'(/"'
$%,('%B'/".#(/$.*"'.#&%,(')4,),(.34.1#"'
2.*(3$)#.*#@'34'&.()*"'&.*?"(,:'
64'.993(3%4I'&.4@'/".#(/$.*"'2*%<39"*,'34'
9"<"#%2"9'&.*?"(,'.*"'"4$)&1"*"9'1@'
#"7.$@'34B*.,(*)$()*",'(/.('/.<"'1""4')4.1#"'
(%'.9.2('(%'&""('(/"'$/.47347'4""9,'%B'
(/"'<"*@'2"%2#"'(/"@'>"*"'9",374"9'(%'
2*%("$(:'J&.##'>%49"*'(/.('&.4.7"&"4('
$%4,)#(.4(,'X$[34,"@'2*"93$('(/.('3B'#"B('.,'3('
3,I'/".#(/$.*"'$%,(,'$%)#9'*".$/'cb'2"*'$"4('
%B'80R'1@'b]b:'C/"';KU0'3,'4%('B.*'1"/349'
>3(/'$%,(,'*".$/347'cb'2"*'$"4('%B'(/"'
&"93.4'80R'1@'bdb:'64'"&"*7347'&.*?"(,'
,)$/'.,'FB*3$.'>/"*"'.9)#('&%*(.#3(@'*.(",'.*"'
%<"*']bb'2"*'eIbbb'2%2)#.(3%4,I'.#%47,39"'
$%,(I'#.$?'%B'34B*.,(*)$()*"I'#3&3("9'.$$",,'(%'
(*".(&"4(,'.49'2%%*'Q).#3(@'&"93$34",'
.*"'(/"'$%*"'/".#(/$.*"'2*%1#"&,:'
f%%?347'./".9'3('3,'/%2"9'(/.(',&.*("*'
("$/4%#%73",'>3##'/"#2'(%'3&2*%<"'
$%&&)43$.(3%4,'1"(>""4'2.(3"4(,I'
/".#(/$.*"'2*%<39"*,'.49'(/%,"'(/.('2.@'.49'
&.4.7"'(/"',@,("&:'F,'.'*",)#('(/3,'/.,'(/"'
2%("4(3.#'(%'3&2*%<"'2.(3"4('B*""9%&'.49'
349"2"49"4$"I'*"9)$"'(/"'%<"*.##'$%,('.49'
3&2*%<"'2.(3"4('$.*":'C/3,'<3">'3,',)22%*("9'
1@'X$[34,"@'(/.('",(3&.(",'(/.('(/"'("#"=
/".#(/'%*'&-".#(/'349),(*@'>3##'1"'>%*(/'
%<"*'MJ'g`b'13##3%4'1@'(/"'"49'%B'(/"'9"$.9":
F'&.Y%*'7#%1.#'$/.##"47"'3,'/%>'(%'#%%?'
.B("*'%)*'"#9"*#@'.49'(/"'$/*%43$.##@'3##:'
X.4@'1"#3"<"'(/.('*%1%(3$'.,,3,("9'$.*"'
.49'*"&%("'&%43(%*347'>3##'%BB"*'<3.1#"'
,)22%*(:'C%9.@'7*%>347'4)&1"*,'%B'2)1#3$'
.49'2*3<.("'%*7.43,.(3%4,'/.<"'&%<"9'%4'
B*%&'1.,3$',@,("&,'%B'4)*,"'<3,3(,'.49'.*"'
.#*".9@'2*%<39347'("#"=/".#(/'1.,"9',)22%*('
(%'&%43(%*'<3(.#',374,'(/*%)7/'9.(.'#34?,I'
73<"'.9<3$"'%<"*'(/"'2/%4"'.49'.##%>'
*"&%("'3&.7347:'C"D('1.,"9',)22%*('%B'
&)#(32#"'2.(3"4(,'/.,'.#,%'2*%<"9'/37/#@'
"BB"$(3<"'B*%&'1%(/'(/"*.2")(3$'.49'
"$%4%&3$'2"*,2"$(3<",'34'&.4@'$%)4(*3",'
B*%&'(/"'R/3#32234",'(%'J%)(/'FB*3$.I'
8"*&.4@'(%'W*.A3#:
By Dr Tim JonesI'P%)49"*'.49'R*%7*.&&"'03*"$(%*'%B'
P)()*"'F7"49.I'.'7#%1.#'%2"4'B%*",37/('343(3.(3<"'
8. Vodafone mHealth Solutions 9
Vodafone mHealth Solutions Insights Guide
64'(/"'4"D('9"$.9"'("#"&"93$34"'
$%44"$(3<3(@'>3##'2*%<39"']hd'&"93$.#'
9.(.',/.*347'1"(>""4'2.(3"4(,'.49'
/".#(/$.*"'2*%B",,3%4,'>3(/'<39"%'#34?,I'
>".*.1#"'&%43(%*347'"Q)32&"4('.49'34=
/%&"',"4,%*,'(*.$?347'&%<"&"4(I'1%9@'
("&2"*.()*"'.49'%(/"*'<3(.#',374,:'C/"'
$%4,"Q)"4$"'%B'(/3,'>3##'1"'(/.('2.(3"4(,'
>3##'1"'.1#"'(%'*"(.34'(/"3*'349"2"49"4$"'
B%*'#%47"*'.49',%'1"(("*'"4Y%@'#3B"'%)(,39"'
(/"'&.34,(*".&'$.*"',@,("&:'J%&"'
commentators as a result envisage a
,#%>=9%>4'34'(/"'*"$"4('7*%>(/'%B'4)*,347'
/%&",'.,'.'7*".("*'2*%2%*(3%4'%B'(/"'"#9"*#@'
remain at home. While some suggest that
(/3,'34'()*4'$%)#9'&".4'34$*".,"9'2/@,3$.#'
3,%#.(3%4I'(/"'.&13(3%4'B%*'%(/"*,'3,'(%'),"'
("$/4%#%7@I'2.*(3$)#.*#@'&%13#"'("$/4%#%7@I'
(%'2*"<"4('2"%2#"'B*%&'B""#347'#%4"#@:'64'.'
>%*#9'>/"*"'%4'.<"*.7"'B.&3#@',)22%*('B%*'
(/"'%#9"*'7"4"*.(3%4'>3##'$%4(34)"'(%'9"$#34"'
.49'(/"'$%,('%B'2*%<39347'2"*,%4.#'$.*"*,'
>3##'$%4(34)"'(%'*3,"I'"#9"*#@'2.(3"4(,'.49'
(/%,"'>3(/'#%47'("*&'$/*%43$'93,".,",'.*"'
34$*".,347#@'#3?"#@'(%',""',%&"',("2'$/.47",'
34',)22%*('%<"*'(/"'4"D('B">'@".*,:'
In addition to automated care there is
7"4"*.#'$%4,"4,),'(/.('1"(("*'),"'%B'
2.(3"4('9.(.'3,'<3(.#'(%'3&2*%<"'"B+$3"4$3",'
5'2.*(3$)#.*#@'B%*'(/%,"'>3(/'%4=7%347I'
$/*%43$'$%493(3%4,',)$/'.,'93.1"(",:'C"$/=
,.<<@'93.1"(3$',)BB"*"*,'.#*".9@'1"4"+('
B*%&'.'7*%>347'4)&1"*'%B'&%13#"'2/%4"'
.22#3$.(3%4,'(/.('$.4'/"#2'*"$%*9'.49'(*.$?'
3493<39).#'&".,)*",I'93"('.49'2"*B%*&.4$"'
.49'(/"*"'.*"'34$*".,347'4)&1"*,'%B',@,("&,'
(/.('.##%>'(/"',/.*347'%B'9.(.'1"(>""4'
2.(3"4(,'.49'(/"3*'9%$(%*,:'W)3#9347'%4'(/3,I'
,"<"*.#'%*7.43,.(3%4,',)22%*('(/"'4%(3%4'
(/.('2""*=(%=2""*'.49'"D2"*('2.(3"4('7*%)2,'
&.@'/.<"'.,'&)$/'34i)"4$"'%4'3493<39).#'
1"/.<3%)*'.,'(/"'&%*"'(*.93(3%4.#'2.(3"4(=
/".#(/$.*"'2*%B",,3%4.#'*"#.(3%4,/32I',%'
"D2"$('(%',""'&%*"'2.(3"4('9.(.'1"$%&347'
&%*"'<3,31#"'.49'&%*"',/.*".1#"'.$*%,,'
2#.(B%*&,'.49',@,("&,'34'@".*,'(%'$%&":
6B'>"'$.4')(3#3,"'(/"'%22%*()43(@'(/.('(/"'
)13Q)3(@'%B'&%13#"'$%&&)43$.(3%4'%BB"*,I'
>"'$.4'1"(("*'B.$3#3(.("'(/"'9"#3<"*@'%B'&%*"'
"B+$3"4('.49'"BB"$(3<"'/".#(/$.*":'dba'%B'(/"'
,3D'13##3%43
'&%13#"',)1,$*31"*,'34'(/"'>%*#9'
(%9.@'#3<"'34'9"<"#%2347'$%)4(*3",'>/"*"'
(/"'4""9'B%*'(/"'2*%<3,3%4'%B'$.*"',"*<3$",'.('
2%34('%B'4""9'3,'7*".(",(:'
KD2"*3"4$"'/.,',/%>4'),'(/.('(/"*"'3,'.'
7*".('>3##3474",,'(%'),"'&%13#"'("$/4%#%7@'
>/"*"'(/"'7"4"*.#'2*%<3,3%4'%B'1.,"#34"'
/".#(/$.*"'3,'>".?",(:'C/"*"B%*"'3('3,'2"*/.2,'
)4,)*2*3,347'(%',""'(/.('(/","'2.*(,'%B'
(/"'>%*#9I')4"4$)&1"*"9'.,'(/"@'.*"'1@'
#"7.$@'34B*.,(*)$()*",I'/.<"'9"&%4,(*.("9'
.4'.13#3(@'(%'1"'43&1#"'34'(/"3*'.9%2(3%4'
%B'4">',%#)(3%4,'(/.('$.4'9"#3<"*'9"$"4('
2"*B%*&.4$"'.('.'#%>'$%,(:'649""9'(/"'
"&"*7347'>%*#9'/.,'1"$%&"'.'$.,"',()9@'
for healthcare innovation.
F'7%%9'"D.&2#"'%B'/%>'&.()*"'&.*?"(,'
.*"'#".*4347'B*%&'%(/"*,'$.4'1"'B%)49'
34'6493.'>/"*"'G.*.@.4.'-%,23(.#'/.,'
),"9'.'$%&134.(3%4'%B'1),34",,'&%9"#'
.49'2*%$",,'344%<.(3%4'(%'#%>"*'(/"'$%,('
%B'$.*93.$',)*7"*@'.49'34'9%347',%'/.,'
*"<%#)(3%43,"9'(/"'.$$",,I'<%#)&"'.49'*".$/'
%B'3(,'B.$3#3(3",'(%'1"$%&"'%4"'%B'(/"'B.,(",('
7*%>347'/".#(/$.*"'1),34",,",'34'(/"'>%*#9:'
F$$%*9347'(%'(/"'!JjI'j.$?'f">34I'UK;'%B'(/"'
F&"*3$.4'U%##"7"'%B'U.*93%#%7@I'(/"'#.*7"'
4)&1"*'%B'2.(3"4(,'2.,,347'(/*%)7/'(/"'
G.*.@.4.'B.$3#3(3",'.##%>,'3493<39).#'9%$(%*,'
(%'B%$),'%4'%4"'%*'(>%',2"$3+$'(@2",'%B'
$.*93.$',)*7"*3",'.49',%'9"<"#%2'2.*(3$)#.*'
,?3##,:'SG.*.@.4.'/.,'4%('%4#@'1"$%&"'(/"'
1",('2#.$"'(%'/.<"'/".*(',)*7"*@'1)('3('/.,'
.#,%'1"$%&"'(/"'7%=(%'B.$3#3(@'B%*'.##'.,23*347'
$.*93.$',)*7"%4,'7#%1.##@T:'
j.$?'f%*9I'UK;'%B'G.<37"43$,I'.)(/%*'%B'(/"'
343(3.#'2"*,2"$(3<"'%4'-".#(/'B%*'(/"'P)()*"'
F7"49.'R*%7*.&&"'%1,"*<"9'(/.(I'S%4'(/"'
2*%<3,3%4347'%B'/".#(/$.*"I'34"*(3.',""&,'
(%'1"'(/"'7*".(",('B%*$"T'.49'>"4('%4'(%'
2*"93$('(/.('S(/"'4"D('9"$.9"'3,'4%('(%'1"'
.'(3&"'%B'$/.47"'1)('34,(".9'.'(3&"'(/.('
,(*",,%*,'%4'(/"',@,("&'1"$%&"'
2*%7*",,3<"#@'"<39"4(O'34$*".,"9'1)*9"4,'
%B'9"&%7*.2/@'.49'$/*%43$'3##4",,'>3##'
*"&.34')4.1.("9T:'6WX'34'(/"3*'J&.*("*'
R#.4"('.4.#@,3,'1)3#9,'%4'(/3,'1@',.@347I'
SC/"'2*%1#"&,'>3(/'%)*'/".#(/$.*"',@,("&'
.*"'>"##'?4%>4'.49'>"##'9%$)&"4("9'5'.49'
"49#",,#@'9"1.("9:'!/.(E,'4%(',%'.22.*"4('
3,'(/.('&.4@'%B'(/"&'.*3,"'1"$.),"'%)*'
/".#(/$.*"',@,("&'3,4E(I'34'B.$(I'.',@,("&:T'
The need to address the rationale for this
34"*(3.'3,'2*",,347'.49'3(',""&,'$#".*'(/.('
&%13#"'("$/4%#%7@'/.,'.'?"@'*%#"'(%'2#.@'
in facilitating change.
Z!"'.*"'34'.'2"*B"$(',(%*&:'k%)E<"'7%('/".#(/$.*"'*"B%*&O'@%)E<"'7%('.4'"$%4%&3$'
9%>4()*4:::'>"'/.<"'.',/%*(.7"'%B'2*%<39"*,:'!"'/.<"'.'2*",,)*"'(%'.9%2('"#"$(*%43$'
*"$%*9,:'!"E<"'7%('.4'.7347'2%2)#.(3%4:'F49'@"(I'.('(/"',.&"'(3&"'>"'/.<"'(/","'
"&"*7347'4">'34B%*&.(3%4I'$%&&)43$.(3%4'("$/4%#%73",'(/.('$.4'/"#2'),'4.<37.("'
(/.('2"*B"$(',(%*&:E'
0.#"'F#<"*,%4I'R*",39"4('%B'(/"'F&"*3$.4'C"#"&"93$34"'F,,%$3.(3%4
!/"(/"*'34'(/"'9"<"#%2347'
"$%4%&3",'%*'34'(/"'!",('&%13#"'
("$/4%#%7@'/.,'.',3743+$.4('
*%#"'(%'2#.@:'6('$.4'9*.&.(3$.##@'
3&2*%<"'(/"'"B+$3"4$@'%B'
/".#(/$.*"'9"#3<"*@'&%9"#,I'B*%&'
,3&2#"'("D('&",,.7"'*"&349"*,I'
(%'3&2*%<347'$%&2#"D',)22#@'
$/.34'2*%$",,",'34'*"&%("'.*".,:'
6('3,'.#,%'>"##',)3("9'(%'3&2*%<347'
2.(3"4('$.*"I'%BB"*347'&"93$.#'
2*%B",,3%4.#,'(/"'.13#3(@'(%'$%##"$('
*".#=(3&"'93.74%,3,'B%*'$#343$.#'
(*3.#,I'73<347'$/*%43$'93,".,"'
sufferers the chance to live more
$%&B%*(.1#@'.49'349"2"49"4(#@'
.('/%&"'.49'2*%<39347'/".#(/$.*"'
>%*?"*,'.$$",,'(%'34B%*&.(3%4',%'
(/.('(/"@'$.4'(*".('&%*"'2.(3"4(,'
&%*"'"BB"$(3<"#@:'
9. ''H%9.B%4"'&-".#(/'J%#)(3%4,''eb
Vodafone mHealth Solutions Insights Guide
Evaluating behaviour
to marketed mHealth
services
F,'&-".#(/'343(3.(3<",'"<%#<"'B*%&'23#%('(%'
&.34,(*".&I'(/3,',"$(3%4'39"4(3+",',%&"'
$%&&%4'.((*31)(",'%B'(/"'&%*"',)$$",,B)#'
343(3.(3<",'%2"*.(347'(%9.@'.$*%,,'.'4)&1"*'
%B'$%)4(*3",'34'(/"'9"<"#%2"9'>%*#9:'
A rapidly evolving space, favouring
the newcomer
&-".#(/'$%&134",'(/"'&%13#"I'6C'.49'
/".#(/$.*"'349),(*3",I'>/3$/'.##'/.<"'
93BB"*"4('2#.@"*,I'2.@"*,I'$)#()*",I'$#%$?'
,2""9,'.49'.((3()9",'(%>.*9,',"$)*3(@I'
2*3<.$@'.49'Q).#3(@:'C/3,'9@4.&3$'.*".'
B.<%)*,'4">$%&"*,I'.49'349""9'&%,('%B'
(/"'$%&2.43",'*"B"*"4$"9'34'(/3,',"$(3%4'
.*"'<"4()*"=1.$?"9',(.*(=)2,'>3(/'*.239#@'
7*%>347'),"*'1.,",'.49',(*%47'$.,/'2%,3(3%4,:'
A space that covers both healthcare
and wellness
C/"'$#".*",('93,(34$(3%4'1"(>""4'
93BB"*"4('$%&2.43",'3,'1"(>""4'/".#(/'
$.*"'.49'>"##4",,O'(/"'B%*&"*'("49'(%'1"'
*"7)#.(%*@=.22*%<"9'&"93$.#'9"<3$",'.49'
,"*<3$",'),"9'1@'9%$(%*,I'>/3#"'(/"'#.(("*I'
,)$/'.,'$.#%*3"'$%)4("*,I'+(4",,'1)993",'
.49',#""2'&%43(%*,I'.*"'(.*7"("9'
at consumers. Wellness solutions
7"4"*.##@'),"'1"/.<3%)*'$/.47"'(%'
9"#3<"*'>"##4",,'7%.#,'l,)$/'.,'#%>"*347'
$.#%*3",I'%*'3&2*%<347'.'`?'*)4'(3&"m'
>/3#"'/".#(/$.*"',%#)(3%4,'.*"'%B("4'9.(.'
7.(/"*"*,'.,'2.*('%B'.'#.*7"*'$#343$.#'
2*%$",,'l,)$/'.,'/".*('&%43(%*,'.49'&%13#"'
XV6,'lX.74"(3$'V",%4.4$"'6&.7347mm:'
Tools for chronic disease management
,)$/'.,'93.1"(",I'/@2"*("4,3%4'.49'
.,(/&.'("49'(%'9*.>'B*%&'1%(/'$.&2,I'
.49'*"2*","4(',%&"'%B'(/"'&%,('"D$3(347'
%22%*()43(3",'B%*'#%>"*347'$%,(,'.49'
3&2*%<347'2.(3"4('%)($%&",:'
C/"'.((*31)(",'#3,("9'/"*"'.*"'$.("7%*3,"9'
.$$%*9347'(%'.9%2(3%4I'"47.7"&"4('.49'
3&2.$('l.#,%',""'+7)*"em:'C/","'>%4E('
.22#@'"Q).##@'(%'.##'$%&2.43",I'/%>"<"*'
&.4@',)$$",,B)#'$%&2.43",'"D/313('(/"'
&.Y%*3(@'%B'(/","'.((*31)(",:'
By Stephen Johnston, Founder and CEO of Fordcastle LLC
>/3$/'/"#2,'9"<"#%2'$%&2.43",'(%'1)3#9'%22%*()43(@'
.*%)49'&%13#"'("$/4%#%7@I'/".#(/$.*"'.49'#%47"<3(@'
Figure 1 The common attributes of
successful mHealth services
IMPACTENGAGEMENT
ADOPTION
Simplicity
Empatheticdesign
Comprehensiveness
Interactive
Customerdelight
Uservalue
Joined-upsolutions
Clincalandeconomicresults
10. Vodafone mHealth Solutions 11
Vodafone mHealth Solutions Insights Guide
F9%2(3%4'
1. Simplicity
8%%7#"E,'F49*%39'.49'F22#"E,'3;J'/.<"'
&.9"'7*".(',(*39",'.('&.?347'$%&2#"DI'
&)#(3=B".()*"9',&.*(2/%4",',3&2#"I'.49'
/.<"'1""4'*">.*9"9'>3(/'.'$%&134"9'_na'
&.*?"(',/.*"'7#%1.##@'34'oc'bee4
:'-%>"<"*I'
(/"'&.Y%*3(@'%B'9"<3$",'34'2"%2#"E,'/.49,'
34'9"<"#%2"9'$%)4(*3",'.*"',(3##'Z9)&1EI'.49'
/".#(/$.*"'2.(3"4(,'34'2.*(3$)#.*'.*"'#3?"#@'
(%'1"'#",,'("$/',.<<@'(/.4'.<"*.7":'649""9I'
%4"'*"$"4(',()9@'B%)49'(/.('%4#@'`a'%B'
2.(3"4(,'>3(/'$/*%43$'93,".,",'>"*"'64("*4"('
users at all5
'l#"('.#%4"'&%13#"'64("*4"('),"*,mI'
>"##'1"#%>'(/"'.<"*.7"'.9)#('2"4"(*.(3%4'
%B'dna6
.
C"D('&",,.7347',"*<3$",'.*"'"BB"$(3<"'.('
9"#3<"*347'1.,3$',"*<3$",I',34$"'(/"@'>%*?'%4'
.#&%,('"<"*@'2/%4"'.49'(/"'*"$323"4('*".9,'
p`a'%B'("D('&",,.7",'>3(/34'B%)*'&34)(",'
of receiving.
H%D3<.I'B%)49"9'34'bbeI'2*%<39",'
C"D(]W.1@'(/.('9"#3<"*,'(/*""'("D(,'.'>""?'
(%'2*%,2"$(3<"'&%(/"*,'.B("*'(/"@'*"73,("*'
(/"3*'13*(/'9.("'),347'.',/%*('$%9":'C/"'("D('
&",,.7",'$%4(.34'"9)$.(3%4.#'$%4("4(I'
*"&349"*,'.49',)*<"@,:'G%>'>3(/'c`?'
,)1,$*31"*,I'(/"',"*<3$"'3,'7*%>347'.('e`?'
),"*,'2"*'&%4(/I'.49',3743+$.4(#@I'%4#@'
cca'%B'.##'),"*,'"<"*'*"73,("*"9'/.<"'
cancelled the service.
C/3,'Z,"('3('.49'B%*7"('3(E'$%4$"2('>%*?,'>"##O'
2.,,3<"',"*<3$",'("49'(%'*"(.34'),"*,'1"(("*'
(/.4'(/%,"'$%4,(.4(#@'*"Q)3*347'9.(.'"4(*@:'
X.4@'$.#%*3"'$%)4("*'.22,'/.<"'i%)49"*"9'
B%*'(/3,'*".,%4I'>/"*".,'>"##4",,'9"<3$",'
,)$/'.,'(/"'!3(/347,'!3=P3'"4.1#"9'1.(/*%%&'
,$.#"I'(/"'P3(13('>".*.1#"'1%9@'&%43(%*'.49'
(/"'q"%',#""2'(*.$?"*'.##'.)(%&.("'9.(.'
$.2()*"'.49'"4(*@'.B("*'343(3.#',"(')2:'
2. Empathetic design
X.*"?'R.>#%>,?3I'B%)49"*'%B'(/"'X%13#"'
M,"*'KD2"*3"4$"'U%4B"*"4$"I'),"9'(/"'("*&'
Z"&2.(/"(3$'9",374E'(%'9",$*31"'(/"'2*%$",,'
%B'"4,)*347'9",374"*,'*".##@'9%'(.?"'(/"'
needs of the end user into consideration.
F('%4"'%B'(/"3*'>%*?,/%2',",,3%4,'%4'
/".#(/$.*"I'2.*(3$32.4(,'34'.'1*.34,(%*&347'
%4'&%13#"'/".#(/'9"<3$",'B%*'(/"'"#9"*#@'
>"*"'73<"4'7#%<",'.49',/.9"9'7#.,,",'(%'
3##),(*.("'(/"'$/.##"47",'B.$"9'>/"4'2"%2#"'
>3(/'<3,).#'.49'2/@,3$.#'3&2.3*&"4(,'/.9'(%'
34("*.$('>3(/'&%13#",:'
C/"'j3(("*1)7'2/%4"'.49',"*<3$"'&.9"'1@'
8*".('U.##'3,'.'&%13#"',%#)(3%4'9",374"9'
>3(/'(/"'4""9,'%B'.7347'),"*,'34'&349'5'>3(/'
#.*7"'?"@,'.49',3&2#"',"*<3$"'%2(3%4,:'C/"@'
offer a medication reminder service for an
.993(3%4.#'&%4(/#@'$/.*7"'(/.('9"#3<"*,'
*"7)#.*'<%3$"'*"&349"*,'(%',)1,$*31"*,'(%'
(.?"'(/"3*'&"93$.(3%4:'
3. Comprehensiveness
P%*',%&"'&-".#(/',%#)(3%4,I'(/"'?"@'(%'
,)$$",,'#3",'34'(/"3*'$%&2*"/"4,3<"4",,:'
P%)49"9'34'eppnI'K2%$*.(",'3,'%4"'%B'(/"'
B">'2)1#3$'$%&2.43",'#3,("9'/"*"'.49'/.<"'
%<"*'.'9"$.9"E,'"D2"*3"4$"'$%##"$(347'.49'
%*7.43,347'$%4("4('B%*'2/@,3$3.4,:'C/"3*'9*)7'
*"B"*"4$"I'"9)$.(3%4.#'.49'$#343$.#',%#)(3%4,'
.*"'34'),"'1@'e:c&'/".#(/$.*"'2*%B",,3%4.#,I'
34$#)9347'%<"*'/.#B'%B'(/"'9%$(%*,'34'(/"'MJI'
>/%'*"#@'%4'3(,'$%&2*"/"4,3<"4",,:
;4'(/"'$%4,)&"*',39"I'(/"'3C*3.7"'.22'(/.('
/.,'1""4'9%>4#%.9"9'.#&%,('(/*""'&3##3%4'
(3&",I',"",')2'(%'%4"'&3##3%4'&%4(/#@'),"*,'
.49'1%.,(,'ebIbbb'l&%,(#@'2%,3(3<"m'*"<3">,'
%4'F22#"E,'F22,(%*":'UK;'R"("*'-)9,%4I'
X0I'/37/#37/(,'3(,'349),(*@=#".9347'$%4("4('
.77*"7.(3%4'$.2.13#3(3",'l34'.993(3%4'(%'
,(*%47'$),(%&"*',)22%*(m'.,'.'?"@',)$$",,'
B.$(%*:'C/"@'2*%<39"'34B%*&.(3%4'.1%)('
,@&2(%&,'.,'>"##'.,'34("7*.(3%4'34(%'
/)49*"9,'%B'2.*(4"*'/".#(/$.*"'2*%<39"*,I'
*",)#(347'34'>/.('3,'"BB"$(3<"#@'1"$%&347'.'
White Pages of consumer health services.
Engagement
4. Interactive
R*%<39347'2"*,%4.#3,"9'B""91.$?'(/.('.##%>,'
users to see the results of their actions
&.?",'B%*'.'&%*"'"47.7347'"D2"*3"4$":'
The Consumer Health Information
U%*2%*.(3%4'lU-6Um'B%)49'(/.('.'Q).*("*'%B'
.##',&.*(2/%4"'.22,'l4%('Y),('/".#(/'.22,m'
>"*"'9*%22"9'.B("*'(/"'+*,('7%I'.49'(/*""=
Q).*("*,'>"*"'4%'#%47"*'),"9'.B("*'(/"'("4(/'
(*@:'V".,%4,'B%*'9*%22347'.4'.22'34$#)9"9'
+49347'.'1"(("*'%4"'lc]:]amI'3(,'#.$?'%B'
S),"*'B*3"49#34",,T'lc:_amI'%*'3('4%('1"347'
"47.7347'"4%)7/'le`:nam:';B'.',)*<"@'%B'
cp`'$%4,)&"*,I'.1%)('nba',.39'(/"@'
>%)#9'1"'&%*"'&%(3<.("9'(%'),"'.4'.22'
(/.('>%)#9'.4.#@,"'9.(.'(/"@'*"$%*9"9'
.49'2*%<39"'B""91.$?7
.
-".#(/$.*"'("$/4%#%7@'$%&2.4@'
!"##0%$I'64$:')49"*,(.49,'(/3,:'
C/"3*'i.7,/32'03.1"(",X.4.7"*®
I'(/"'+*,('
&%13#"'93.1"(",'&.4.7"&"4(',%#)(3%4'(%'
*"$"3<"'P0F'`eb['$#".*.4$"I'2*%<39",'
,3&2#"'.49'2*%<"4I'$#343$.#'.49'1"/.<3%)*.#'
"<39"4$"=1.,"9'7)39.4$"'.1%)('/%>'(%'
&.4.7"'7#)$%,"'#"<"#,I'&"93$.(3%4,I'
.$(3<3(@I'93"('.49',"<"*.#'%(/"*'2.*.&"("*,'
>/3$/'.BB"$('(%(.#'93.1"(",'>"##4",,:'
U%&2.4@'R*",39"4('F4.49'6@"*',"",'3('.,'
.'S&%13#"'<3*().#'$%.$/347',%#)(3%4T'(/.('
2*%<39",'1.,3$'$#343$.#'.49'1"/.<3%)*.#'
,)22%*(I'"BB"$(3<"#@'2*%<39347'.4'34("*.$(3<"'
$%.$/'34'2"%2#"E,'2%$?"(,:
11. ''H%9.B%4"'&-".#(/'J%#)(3%4,''e
Vodafone mHealth Solutions Insights Guide
Z!"E<"',""4'&.4@'2*%7*.&&",'(/.('/.<"'1""4'7*.4('B)49"9:'C/"'7*.4('"49,'.49'(/"'
2*%7*.&&"'"49,:'J%'>"'.,?'2"%2#"'(%'(/34?'.1%)(',),(.34.13#3(@'.49'(%'$%&"')2'>3(/'
.'1),34",,'2#.4'(/.('&.?",',"4,":'!/.(E,'(/"'9.(.'>"'4""9'(%'$%##"$('(%',/%>'(/"'
3&2.$('.49'>/.('.*"'(/"'3493$.(%*,'%B',)$$",,:'k%)E<"'7%('(%'1"'.1#"'(%'9"("*&34"'(/.(:'
C"#"/".#(/'>3##'4%('1"',),(.34"9'%*'.9%2("9')4#",,'>"'$.4',/%>'(/.('3('3&2*%<",'/".#(/'
%)($%&",'.49'*"9)$",'$%,(,:E'
U#343$3.4I'MJ
5. Customer delight, even fun
P)4$(3%4'/.,'7"4"*.##@'(*3)&2/"9'%<"*'
B%*&'34'(/"'/".#(/$.*"'1),34",,I'>/3#"'34'
(/"'$%4,)&"*'"#"$(*%43$,'.49'&%13#"',2.$"'
.'<.,('.&%)4('%B'(3&"'3,',2"4('(/34?347'
.1%)('),"*'"D2"*3"4$":'
C/"'W%,(%4I'XF=1.,"9',(.*(=)2'
P3(4",,[""2"*'/.,'.((*.$("9'_&'),"*,'(%'3(,'
V)4[""2"*',"*<3$"'>3(/%)(',2"49347'.'$"4('
%4'.9<"*(3,347:'P%)49"*'r'UK;'j.,%4'j.$%1,'
(/34?,'(/.('S1)3#9347'.'2*%9)$('2"%2#"'
#%<"T'3,'(/"'?"@'(%'(/3,'%*7.43$'7*%>(/:'64'
.993(3%4I'/"'$3(",'(/"',%$3.#'$%&2%4"4(I'
.$$"#"*.("9'1@'P.$"1%%?'.49'C>3(("*I'.49'
(/"'$%&&)43(@',)22%*(I'.,',)$$",,'B.$(%*,:'
0"#37/('9%",4E('/.<"'(%'1"'*","*<"9'B%*'
>"##4",,'.22,:'C/"'B%)49"*,'%B'HU=1.$?"9'
,(.*(=)2'X.,,3<"'-".#(/'.*"'),"*'"D2"*3"4$"'
"D2"*(,'>3(/%)('/".#(/$.*"'1.$?7*%)49,I'
.49'/.<"'<%>"9'(%'1*347'$),(%&"*'9"#37/('
(%'(/"'+"#9'%B'/".#(/$.*":'C/"@'.*"'$)**"4(#@'
1"(.'(",(347'(/"3*'+*,('2*%9)$(I'.'93.1"(",'
&.4.7"&"4(',%#)(3%4I'.49'UK;'J)(/.'
[.&.#',.@,'(/.(')#(3&.("#@'/"E,'S#%%?347'
B%*'(/"'7*34T'%4'(/"'),"*E,'B.$":'64'.993(3%4I'
344%<.(3<"'2*%Y"$(,'.*"'),347'X3$*%,%B(E,'
[34"$(E,'&%(3%4=,"4,347',%#)(3%4'(%'.,,",,'
".*#@'93,".,"',@&2(%&,8
I'.49'7.&"'
9@4.&3$,'.*"'1"347'),"9'(%'"4$%)*.7"'
&"4(.#'.49'2/@,3$.#'+(4",,I',)$/'.,'>3(/'
-)&.4.E,'U%#%*B.##:
6&2.$(
6. User value
J&.*(',%#)(3%4,'9%'&%*"'(/.4'Y),('
*"2#3$.("'"D3,(347'2*%$",,",'%4',&.##'
,$*""4,I'(/"@'#%%?'B%*'>.@,'34'>/3$/'(/"'
2*%$",,'$.4'1"'9%4"'1"(("*I'9"#3<"*347'
#.,(347'),"*'1"4"+(,'(/.(',3743+$.4(#@'
%)(>"37/'.4@'$%,(,'34$)**"9:'
FA)&3%E,'Z64,(.4('-".*('V.("E'.22'9"#3<"*,'
Y),('>/.('3('2*%&3,",I'(.?347'(/"'/".*('*.("'
B*%&'(/"'+47"*'34'Y),('.'B">',"$%49,:'6('
),",'(/"'2/%4"E,'34=1)3#('$.&"*.'$%&134"9'
>3(/'(/"'#37/('B*%&'(/"'i.,/'(%'(*.$?'$%#%)*'
$/.47",'34'(/"',?34'(/.(',/%>'/".*('*.(":'
C/3,'344%<.(3<"'.22*%.$/I'(%7"(/"*'>3(/'.4'
attractive user interface has resulted in this
.22'1"347'9%>4#%.9"9'eb'&3##3%4'(3&",'1@'
;$(%1"*'bebO'.('gb:pp'.'9%>4#%.9I'(/3,'/.,'
1"$%&"'%4"'%B'&-".#(/E,',)$$",,',(%*3",:'
J%#)(3%4,'(/.('&.?"'B)##'),"'%B'(/"'&)#(3=
B.$"("9'2%>"*'%B'(/"'&%13#"'$.4'9"#3<"*'
even more value to users than those that
Y),('*"2#3$.("'"D3,(347'%Bi34"'2*%$",,",:'
C/3,'3,'",2"$3.##@'3&2%*(.4('>/"4'%4"'
$%4,39"*,'(/"'&@*3.9'%B'"D3,(347'93,(*.$(3%4,'
%4'(/"'2/%4"'(/.('.*"'.#*".9@'$%&2"(347'
B%*'(/"'),"*E,'.(("4(3%4I',)$/'.,'?""2347')2'
>3(/',%$3.#'4"(>%*?,I'$%4,)&347'&"93.'%*'
2#.@347'7.&",:
7. Clinical and economic results
-".#(/=B%$),"9',%#)(3%4,'(/.('$.4',/%>'
1%(/'$#343$.#'.49'"$%4%&3$'1"4"+(,'(%'.##'
2.*(3",'>3##',""'(/"'&%,('*.239')2(.?":'
F3*J(*32'C"$/4%#%73",'9"#3<"*,'4".*'*".#=(3&"'
>.<"B%*&'.49'%(/"*'*"#"<.4('$#343$.#'9.(.'(%'
.'2/@,3$3.4E,',&.*(2/%4":'C/"'$%&2.4@E,'
;W'2*%9)$('/.,'1""4',%',)$$",,B)#'
34'*"9)$347'/)&.4'"**%*,I'(/.(',%&"'
&.#2*.$(3$"'34,)*.4$"'$%&2.43",'34'(/"'
MJ'.*"',)1,393,347'(/"'$%,(,'B%*'9%$(%*,'
(%'),"'3(:'64'.993(3%4I'34("*4.#',()93",'/.<"'
,/%>4'(/.('(/"3*'$.*93%#%7@',%#)(3%4'$.4'
$)(',/%*('(/"'(3&"'B*%&'KXJ'lK&"*7"4$@'
X"93$.#'J"*<3$",m'(%',)*7"*@'1@')2'(%'e`'
&34)(",I'.49'*"9)$",'(/"'.<"*.7"'(3&"'
,2"4('34'/%,23(.#'B%##%>347'.'/".*('.((.$?'
1@'.#&%,('.'9.@:'
F',$3"4(3+$',()9@'*"2%*("9'34'(/"'J"2("&1"*'
bee'"93(3%4'%B'(/"'Y%)*4.#'%B'(/"'F&"*3$.4'
03.1"(",'F,,%$3.(3%4I',/%>,'(/.('!"##0%$E,'
03.1"(",X.4.7"*®
'9"#3<"*"9'.'e:pa'9"$#34"'
%<"*'.'@".*'34'(/"'?"@'93.1"(",'&"(*3$'
lFeU'5'8#@$.("9'/."&%7#%134mI'$%&2.*"9'
(%'b:da'34'(/"'(",('7*%)2:'!3(/'".$/'ea'
34$*".,"'34'(/"'FeU'#"<"#'*"2*","4(347'.'
s]ba'34$*".,"9'*3,?'%B'&3$*%'.49'&.$*%'
<.,$)#.*'$%&2#3$.(3%4,'B%*'93.1"(",'2.(3"4(,I'
.49'.4'.<"*.7"'&%4(/#@'$%,('%B'%<"*'gcbbI'
*",)#(,',)$/'.,'(/","'&.?"'3('&%*"'#3?"#@'
(/.('2/@,3$3.4'.49'*"7)#.(%*,'>3##'*.239#@'
.9%2('.49'"&1*.$"'(/","',"*<3$",:'
13. Vodafone mHealth Solutions 14
Vodafone mHealth Solutions Insights Guide
V"7)#.(%*@'$%&2#"D3(@I'+4.4$3.#'
$%4,(*.34(,I'"4(*"4$/"9'34B*.,(*)$()*",'
.49'2%%*'34<",(&"4('34'("$/4%#%7@'
$%&134"9'>3(/'.'#.$?'%B')49"*,(.49347'
1@'("$/4%#%7@'2*%<39"*,'/.,'&".4('(/.('
9373(.#'344%<.(3%4'34'/".#(/$.*"'/.,'1""4'
,#%>'(%'(.?"'/%#9:'-%>"<"*I'73<"4'$/.47347'
/".#(/$.*"'4""9,'%B'.4'34$*".,347#@'.7"347'
2%2)#.(3%4'.49'(/"'$/.##"47",'2*","4("9'
1@'(/"'$)**"4('"$%4%&3$'$*3,3,I'(/"*"'
3,'*"4">"9'34("*",('34'(/"'2%("4(3.#'%B'
&-".#(/'.49'64("*4"(',%#)(3%4,'(%'/"#2'
*"9)$"'$%,(,I'34$*".,"'"B+$3"4$3",'
and effectiveness.
C/3,',"$(3%4'$%4,39"*,'(/"'2*.$(3$.#'*".,%4,'
1"/349'(/"',#%>"*'(/.4'"D2"$("9'.9%2(3%4'
of digital health technologies and discusses
"D2"*3"4$",'B*%&'%(/"*',"$(%*,'(/.('$%)#9'
2%("4(3.##@'/"#2'$*".("'>39"',$.#"'.9%2(3%4:
Creating a better customer-centric
experience
M49"*,(.49.1#@'2.(3"4(,'.49'2/@,3$3.4,'
>%)#9'2*"B"*'(%'&.4.7"'/".#(/$.*"'
,"*<3$",'34'.',3&2#"'.49',(*.37/(B%*>.*9'
>.@:'-%>"<"*'&.4@'#3B"',$3"4$"'$%&2.43",'
(%'9.("'/.<"'4%('.$?4%>#"97"9'(/3,'.49'
/.<"'34,(".9',"(')2'.'93,2.*.("',"('%B'
34("*B.$",'>/3$/'.*"'(3*",%&":
F$*%,,'#3B"',$3"4$"'$%&2.43",I'(/"'
9"B.)#('.22*%.$/'(%'%4#34"'34("*.$(3%4'3,'
.',(.49.*9',(.(3$'>"1,3("9
'>/"*"'2*%9)$('
34B%*&.(3%4'$.4'1"'B%)49'34'%4"'2#.$"I'
$%&2.4@'34B%*&.(3%4'34'.4%(/"*I'.49'
(/"*"'3,'4%'%1<3%),'%<"*<3">'%B'(/"'<.#)"=
.99"9',"*<3$",'2*%<39"9:'C/3,'3,'.'/)7"'
&3,,"9'%22%*()43(@:
R"*/.2,'#3B"',$3"4$"'%*7.43,.(3%4,',/%)#9'
#%%?'(%'%(/"*',"$(%*,'B%*'7)39.4$":'
F&.A%4E,'>"1,3("'B%*'"D.&2#"'$.4'73<"'
@%)'.#&%,('.4@(/347'@%)'4""9'>3(/'.'
,347#"',".*$/'B)4$(3%4'.49'.'B">'$#3$?,:'
K<"*@'2)*$/.,"'B%##%>,'(/"'"D.$(',.&"'
,3&2#"'2.(("*4'.49'@%)'9%4E('4""9'(%'
+##'%)('@%)*'2.@&"4('%*'9"#3<"*@'9.(.'.'
,"$%49'(3&":'64'.993(3%4I'F&.A%4'),",'
,%$3.#'*"$%&&"49.(3%4,'.49'2*"93$(3<"'
&.*?"(347'(%'/"#2'@%)'.,'.4'3493<39).#'
(%'+49'(/"'(/347,'@%)'9394E('"<"4'?4%>'
@%)'4""9"9'@"(:';4"'(*),(>%*(/@'2.*(4"*'
(/.('?4%>,'@%)*'2*"B"*"4$",'.49',)22%*(,'
@%)'.$$%*9347#@I'.'9*".&'$%&"'(*)":::'
,%'>/@'.*"'#3B"',$3"4$",'$%&2.43",'4%('
"&1*.$347'(/3,^
F9&3(("9#@I'(/"'349),(*@'3,'#".*4347'5'1)('
,#%>#@:'C.?"'B%*'"D.&2#"'(/"'MJ'1.,"9'
9373(.#'/".#(/$.*"'2%*(.#'-".#(/8*.9",:'
6('/"#2,'2.(3"4(,'+49'9%$(%*,'.$$%*9347'
(%'(/"3*'4""9:'f"(E,',.@'@%)'4""9'(%'+49'
.'$.*93%#%73,('$#%,"'(%'G">'k%*?I'(/"4'
@%)'$.4'+49'&%*"'(/.4'`bb'2%,,31#"'Gk'
$.*93%#%73,(,'%4'(/3,'2%*(.#:'-%>'9%'@%)'
?4%>'>/3$/'2/@,3$3.4'>3##'2*%<39"'(/"'
1",('$.*"^'C/*%)7/'/37/=<%#)&"'2.(3"4('
*.(347,I'(/"'2/@,3$3.4,'.*"'*.4?"9'
$%4<"43"4(#@'.49'@%)'$.4'3&&"93.("#@'
+49'(/"'2/@,3$3.4'%B'@%)*'$/%3$":'
)"*%+",%$-./*"0,.1(",.2"$"#&
SC/"'#.,('(>"4(@'@".*,'>"*"'.1%)('
1"$%&347'9373(.#I'(/"'4"D('(>"4(@'@".*,'
>3##'1"'.1%)('1"$%&347'$#"<"*'>3(/'9373(.#TI'
,.@,'U/.3*&.4'%B'F$*%,,'C"$/4%#%7@I'R"("*'
-34,,"4:'C/3,'&37/(',%)49'(*3("'1)('34'%*9"*'
(%'),"'("$/4%#%7@'$),(%&"*,'&),('+*,('
By Fonny Schenck,
UK;'.('F$*%,,'-".#(/I'.4'
international management
$%4,)#(.4$@'B%*'9373(.#'
innovation in life sciences
Adopting technology:
understanding the challenges
for healthcare professionals
14. Vodafone mHealth Solutions 15
Vodafone mHealth Solutions Insights Guide
)49"*,(.49'3(,'1"4"+(,:'649""9'34'.'>.@'
("$/4%#%73,(,'/.<"'1""4'93,(*.$("9'1@'(/"'
$%4$"2('%B'("$/4%#%7@'5'.49'34,(".9'%B'
>%*?347'(%>.*9,'1"(("*',"*<3$",'/.<"',2"4('
(%%'&)$/'(3&"'(*@347'(%'1)3#9'.'$#"<"*"*'
,@,("&:'F3*J(*32'UK;'F#.4'R%*("#.'"D2#.34"9'
(/3,'34'(/"'$%4("D('%B'K#"$(*%43$'X"93$.#'
V"$%*9,I'KXV,L'SKXV,'.*"'2#.(B%*&,I'C/"'
,.&"'>.@'(/.('@%)*'$%&2)("*'/.,'.4'
t%2"*.(347',@,("&u'5'KXV,'.*"'(/"';J:'
k%)'1"4"+('B*%&'(/"'.22,'(/.('@%)'2)('%4'
(%2'%B'(/"';JI'>/3#"'@%)'9%4E('1"4"+(',%'
much from the OSeb
:T';B'$%)*,"'>3(/%)('
(/"';2"*.(347'J@,("&'(/"'.22,'>%)#9'4%('
>%*?'1)(',(3##I'(/"'2%34('4""9,'(%'1"'&.9":'
&-".#(/'("$/4%#%7@'2*%<39"*,'>%)#9'9%'
>"##'(%'1".*'(/3,'34'&349'>/"4'$%4,39"*347'
2*%9)$('344%<.(3%4,:
Right place, right technology, right
doctor and right patient
64'(/"'B)()*"'/".#(/$.*"'>3##'1"'9"#3<"*"9'
through a multitude of channels and it
3,'$#".*'(/.('&%13#"'9"<3$",'>3##'/.<"'.'
93,(34$('*%#"'(%'2#.@'34'(/3,:'W)('&%13#"'
9"<3$",'.*"'4%('(/"'%4#@'%2(3%4I'%(/"*'
9"<3$",'%*'$/.44"#,',/%)#9'.49'>3##'1"'
),"9'>/"4'&%*"'.22*%2*3.(":
G%('%4#@'9%'$"*(.34'9"<3$",'+('$"*(.34'
$%4("D(,'1"(("*I'(/"',"*<3$",'2*%<39"9'
on these devices should integrate as
,".&#",,#@'.,'2%,,31#"'>3(/'(/"'4%*&.#'
>%*?'2.(("*4,'%B'(/"'/".#(/$.*"'2*%B",,3%4.#'
.49'2.(3"4(:'P.3#)*"'(%'.$/3"<"'(/3,'/.,'34'
(/"'2.,('#"9'(%',3743+$.4('+4.4$3.#'
34<",(&"4('>3(/%)('.4@'&.("*3.#'7.34:
mHealth technologists need to consider
/%>'1",('(%'+('(/"3*',"*<3$"'34(%'(/"'
2.(3"4(,E'9.3#@'#3<",'%*'(/"'2/@,3$3.4,E'
4%*&.#'>%*?i%>:'C/"'?"@'Q)",(3%4'(/"@'
,/%)#9'.,?'3,'/%>'$.4'>"'&.?"'(/"3*'#3<",'
".,3"*I'.49'4%('&%*"'93B+$)#(^'
Understanding pricing and
reimbursement dynamics
C/"'34("*4"('/.,'*.93$.##@'(*.4,B%*&"9'
2*3$347'&%9"#,'.49'&.4@'%*7.43,.(3%4,'
.*"'1.((#347'(%'.9.2('(%'(/3,:'64$*".,347#@'
SB*""&3)&T'&%9"#,'$%&134"9'>3(/'
advertising have great success. There
.*"'.##',%*(,'%B'>.@,'%B'.9%2(347'.'
B*""&3)&'.22*%.$/:'P%*'"D.&2#"I'34'/3,'
1%%?'SP*""L'(/"'P)()*"'%B'.'V.93$.#'R*3$"T'
U/*3,'F49"*,%4'9",$*31",'/%>'2*.$(3$"'
&.4.7"&"4(',%B(>.*"'3,'73<"4'.>.@'1@'
(/"'U.#3B%*43.4'$%&2.4@'R*.$(3$"'P),3%4:'
C/"'2/@,3$3.4,'.*"'73<"4'(/"'B*""'<"*,3%4'%B'
(/"',%B(>.*"'>3(/'.9,'%*'$.4'1)@'.4'.9=B*""'
<"*,3%4'B%*'ebb'MJ0'2"*'&%4(/:'F993(3%4.#'
<.#)"'3,'$*".("9'1@',"##347'.4%43&3,"9'
2.(3"4('$/.*(,'(%'&"93$.#'.,,%$3.(3%4,'
B%*'*",".*$/'2)*2%,",:'ebbIbbb'&"93$.#'
2*%B",,3%4.#,'.*"'$)**"4(#@'),347'(/"'
,"*<3$"'.49'(/"'4)&1"*'3,'7*%>347I'>3(/'
c`b'4">'),"*,'"<"*@'9.@11
.
J(.49.*9'/".#(/$.*"'2*.$(3$"'3,'
,%&">/.('93BB"*"4('(%'(/3,:'64'9"<"#%2"9'
"$%4%&3",'$%&&%4'2*.$(3$"'3,'(%'*"#@'%4'
*"3&1)*,"&"4('B*%&'(/"'7%<"*4&"4(I'34'
>/3$/'$.,"'(/"'("$/4%#%7@'3,'$%4,39"*"9'
l4".*#@m'B*""'B%*'(/"'"49'),"*:'64'&%,('
$%)4(*3",I'9%$(%*,'.*"'2.39'1.,"9'%4'(/"'
4)&1"*'%B'2.(3"4(,'(/"@'(*".('%*'&""('
in the consulting room. If doctors are
*">.*9"9'34'(/3,'>.@'3('3,'<"*@'$#".*'>/@'
(/"@'.*"'*"(3$"4('34'.9%2(347'("$/4%#%73",'
(/.('*"9)$"'B.$"=(%=B.$"'34("*.$(3%4,:'P*%&'
(/.('2"*,2"$(3<"I'349""9L'!/.('(%'(/"&'3,'
(/"'1"4"+('%B'*"&%("'&%43(%*347^'
An interesting recent initiative from
F),(*.#3.')49"*,$%*",'(/"'3&2%*(.4$"'
%B'*"3&1)*,"&"4(h34$"4(3<",'34'(/"'
.9%2(3%4'%B'4">'("$/4%#%73",L',34$"'
j)#@'bee'.49'B%*'(/"'4"D('B%)*'@".*,I'
(/"'F),(*.#3.4'7%<"*4&"4('3,'.$(3<"#@'
2*%&%(347'("#"/".#(/'1@'2*%<39347'1%4),",'
(%'/".#(/$.*"'2*%B",,3%4.#,'(/.('.9%2('
("#"/".#(/'("$/4%#%7@'.49'(/.('2.*(3$32.("'
34'<39"%=$%4,)#(,'>3(/'2.(3"4(,:
U*%,,347'(/"'l&-".#(/m'$/.,&
8"%BB*"@'F:'X%%*"E,'1%%?'SU*%,,347'(/"'U/.,&T'9",$*31",'(/"'7*".(",('
93B+$)#(@'(/.('&.4@'93,*)2(3<"'("$/4%#%73$.#'344%<.(3%4,'B.$"'34'$*%,,347'
(/"'$/.,&'1"(>""4'344%<.(%*,'.49'".*#@'.9%2("*,:'6('3,'$#".*'(/.('(/"'
2*3%*3(3",'%B'9%$(%*,'.49'/".#(/$.*"'>%*?"*,'.*"'<"*@'93BB"*"4('B*%&'(/.('
%B'(/"'("$/4%#%73,(:'C/"'1",(',(3&)#),'(%'(/"'.9%2(3%4'%B'&-".#(/'3,'(%'
()*4'(/"'.1%<"'/)*9#",'34(%'9*3<"*,L'2)((347'(/"'$),(%&"*'.('(/"'/".*('%B'
@%)*'1),34",,I'%BB"*347')4,)*2.,,"9'),"*'1"4"+(,I'9",374347'B%*'(/"'*37/('
),"'$%4("D(I'.49'%BB"*347'.4'.((*.$(3<"'2*3$347'&%9"#:
15. Vodafone mHealth Solutions 16
Vodafone mHealth Solutions Insights Guide
Understanding health
psychology and the
science of behaviour
Introduction
-.<347'"<.#).("9'.'4)&1"*'%B'&-".#(/'
,"*<3$",'%4'(/"'1.,3,'%B',)$$",,'34'),"*'
.9%2(3%4I'(/3,'#.,(',"$(3%4'%B'(/"'*"2%*('
.3&,'(%'$%4("D().#3,"'(/"'$)**"4(',(.("'
of mHealth through relevant academic
#3("*.()*"'%4'),"*'.9%2(3%4'1"/.<3%)*:
C/"*"'3,'.'7*%>347'$%*2),'%B'#3("*.()*"'
9%$)&"4(347'(/"'9"<"#%2&"4('%B'93BB"*"4('
mHealth technologies. Alongside technical
.,2"$(,I'93,$),,3%4,'"D2#%*"'3,,)",'%B'
93,,"&34.(3%4'.49'3&2#"&"4(.(3%4I'.49'
(/"*"'/.<"'1""4'.'4)&1"*'%B'2*"#3&34.*@'
"<.#).(3%4,'34'("*&,'%B'3&2.$('%4'/".#(/'
%)($%&",I'2.(3"4(',.(3,B.$(3%4'.49'
1"/.<3%)*'$/.47":'!/.('3,'#.*7"#@'.1,"4('
B*%&'(/"'2)1#3,/"9'#3("*.()*"I'/%>"<"*I'
3,'*37%*%),'*",".*$/'%4'(/"'2*%$",,'%B'
)2(.?"'.49'.9%2(3%4'%B'&-".#(/'B*%&'
(/"'2"*,2"$(3<"'%B'1%(/'(/"'2.(3"4('.49'
/".#(/$.*"'2*%<39"*:'64'(/3,',"$(3%4I'
(/"*"B%*"I'>"'.99*",,'(>%'&.34'Q)",(3%4,L
N''!/.('"D3,(347'(/"%*3",'.49'*",".*$/'$.4'
1"'),"9'(%'"D2#.34'.9%2(3%4'1"/.<3%)*'%B'
("$/4%#%73",'%B'/".#(/^'
N''!/.('$%4,(3()("'(/"'&.34'1.**3"*,'(%'
&-".#(/'.9%2(3%4^
Existing theories
-".#(/=*"#.("9'1"/.<3%)*'3,'/37/#@'$%&2#"D'
and efforts to understand and account
B%*'3493<39).#'.49'$%##"$(3<"'1"/.<3%)*'
and its determinants continue across
&)#(32#"'93,$32#34",:'0*.>347'%4'(/"%*"(3$.#'
B*.&">%*?,'B*%&'.4(/*%2%#%7@I'/".#(/'
2,@$/%#%7@I',%$3%#%7@'.49'$)#()*.#'
"239"&3%#%7@I'(/"'B%##%>347'2*","4(,'.'1*3"B'
%)(#34"'%B',"#"$("9'(/"%*3",'%B'1"/.<3%)*'
.,'(/"@'*"#.("'(%'/".#(/$.*"'2*.$(3$",'.49'
/".#(/',@,("&'*",2%4,":
The Health Belief Model
P3*,('9"<"#%2"9'34'(/"'ep`b,'1@',%$3.#'
2,@$/%#%73,(,'-%$/1.)&I'V%,"4,(%$?'.49'
["7"#,eIec
I'(/3,'&%9"#'.(("&2(,'(%'"D2#.34'
.49'2*"93$('/".#(/'1"/.<3%)*,'1@'B%$),347'
%4'(/"'.((3()9",'.49'1"#3"B,'%B'3493<39).#,:'
C/"'&%9"#'3,',(*)$()*"9'.*%)49'B%)*'?"@'
$%4$"2(,'>/3$/'.$$%)4('B%*'.4'3493<39).#E,'
*".934",,'(%'.$(L
N'2"*$"3<"9',),$"2(313#3(@'
N'2"*$"3<"9',"<"*3(@'
N'2"*$"3<"9'1"4"+(,'
N'2"*$"3<"9'1.**3"*,
F993(3%4.#'$%4$"2(,I'$)",'(%'.$(3%4'
.49',"#B="B+$.$@I'>"*"'#.("*'.99"9'(%'
/"#2'(/"'-".#(/'W"#3"B'X%9"#'.99*",,'
/.13().##@')4/".#(/@'1"/.<3%)*,',)$/'.,'
,&%?347I'%<"*".(347'.49'1"347',"9"4(.*@'
l$%493(3%4,'(/.('&-".#(/'("$/4%#%73",'
/.<"'.99*",,"9m:'W"#3"B'.49'/".#(/'
&%(3<.(3%4'.*"',""4'(%'1"'$%493(3%4"9'
1@',%$3%=9"&%7*.2/3$'<.*3.1#",'.49'
(/"'2,@$/%#%73$.#'$/.*.$("*3,(3$,'%B'
(/"'3493<39).#:'C/"'&%9"#'/.,'1""4'
),"9'"D("4,3<"#@'34'9"("*&34347'/".#(/'
2*%&%(3%4'.$(3<3(3",14
:'-%>"<"*I'3('B.3#,'(%'
34$%*2%*.("'B".()*",',)$/'.,'(/"'34i)"4$"'
%B'2*"<3%),'"D2"*3"4$"I'.9<.4(.7",'%B'&.#=
.9.2(3<"'1"/.<3%)*I'1"/.<3%)*.#'34("4(3%4'
.49'2"*$"3<"9'$%4(*%#:
By Dr Juliet BedfordI'P%)49"*'.49'03*"$(%*'%B'F4(/*%#%73$.I'
.'*",".*$/'1.,"9'$%4,)#(.4$@'+*&',2"$3.#3,347'34'(/"'
.22#3"9'.4(/*%2%#%7@'%B'/".#(/$.*"
16. Vodafone mHealth Solutions 17
Vodafone mHealth Solutions Insights Guide
Theory of Planned Behaviour
F4'"D("4,3%4'%B'(/"'C/"%*@'%B'V".,%4"9'
F$(3%4I'B%*&)#.("9'1@'FYA"4'.49'P3,/1"34'
34'epnb15
I'>/3$/',%)7/('(%'",(3&.("'
(/"'93,$*"2.4$@'1"(>""4'.((3()9"'
.49'1"/.<3%)*I'(/"'C/"%*@'%B'R#.44"9'
W"/.<3%)*'l.#,%',""'+7)*"'m16
'2*"93$(,'
9"#31"*.("'1"/.<3%)*.#'34("4(3%4'),347'
(/*""'$%4,(*)$(,L'1"/.<3%)*.#'1"#3"B,I'
4%*&.(3<"'1"#3"B,'.49'$%4(*%#'1"#3"B,:'
N''W"/.<3%)*.#'1"#3"B,'l.((3()9",'(%>.*9,'
(/"'1"/.<3%)*m'.*"'9"("*&34"9'1@'(/"'
4%(3%4'(/.('.',2"$3+$'1"/.<3%)*'>3##'/.<"'
a concrete consequence.
N''G%*&.(3<"'1"#3"B,'l(/"',)1Y"$(3<"'4%*&m'
.*"'$%4$"*4"9'>3(/'<3">,'.1%)('/%>'
2"%2#"'5'(/"'3493<39).#E,',%$3.#'4"(>%*?'
5'>3##'*"7.*9'(/"'1"/.<3%)*'34'Q)",(3%4I'
2#),'2"*,%4.#'&%(3<.(3%4'(%'B)#+#'(/"'
"D2"$(.(3%4'%B'%(/"*,:'
N''U%4(*%#'1"#3"B,'l2"*$"3<"9'1"/.<3%)*.#'
$%4(*%#m'*"B"*'(%'.4'3493<39).#E,'
2"*$"2(3%4'%B'(/"3*'.13#3(@'(%'2"*B%*&'.'
73<"4'1"/.<3%)*I'1"#3"B'.1%)('.$$",,'(%'
the resources needed in order to
.$(',)$$",,B)##@:'
C/","'2*"93$(%*,'#".9'(%'34("4(3%4I'(/"'
2*"$)*,%*'%B'1"/.<3%)*:'64'7"4"*.#I'(/"'
&%*"'B.<%)*.1#"'(/"'.((3()9"'.49'(/"'
,)1Y"$(3<"'4%*&I'(/"'7*".("*'(/"'2"*$"3<"9'
$%4(*%#I'(/"',(*%47"*'.'2"*,%4E,'34("4(3%4'
(%'2"*B%*&'(/"'1"/.<3%)*'34'Q)",(3%4:'C/"'
.9<.4(.7"'%B'(/"'2*.$(3$.#'.22#3$.(3%4'%B'
(/3,'(/"%*@'3,'(/.('3('(.?",'34(%'.$$%)4('
&%(3<.(3%4.#'.,2"$(,'%B'2"*,%4.#'$%4(*%#'
.49'(/"'34i)"4$"'%B',%$3.#'4"(>%*?,I'1)('
3('$.4'1"'#3&3("9'1@'.4'%<"*="&2/.,3,'%B'
2,@$/%#%73$.#'B.$(%*,'>/3#,(')49"*=<.#)347'
structural forces such as the reduced
.<.3#.13#3(@'%B'*",%)*$",'%*'2%%*'.$$",,:
Healthcare Utilisation Model
0"<"#%2"9'1@'F49"*,%4'.49'G">&.417
34'(/"'epdb,I'(/3,',%$3%=1"/.<3%)*.#'
&%9"#'7*%)2,'(/*""'$#),("*,'%B'B.$(%*,'
(/.('$.4'34i)"4$"'/".#(/'1"/.<3%)*'34'.'
#%73$',"Q)"4$"L'
N'2*"93,2%,347
N'"4.1#347'
N need factors
C/3,'&%9"#'>.,'9"<"#%2"9'(%'34<",(37.("'
(/"'),"'%B'13%&"93$.#'/".#(/',"*<3$",I'
.#(/%)7/'#.("*'<"*,3%4,'>"*"'"D("49"9'
to include other healthcare sectors18
.
6('$"4(*",',2"$3+$.##@'%4'(*".(&"4('
,"#"$(3%4'.49'34$#)9",'1%(/'&.("*3.#'
.49'#%73,(3$.#'B.$(%*,'(/.('.*"'4%('B)##@'
.$$%)4("9'B%*'34'%(/"*'&%9"#,:'[*%"7"*19
"#.1%*.("9'(/"'&%9"#'(%'34$#)9"'/".#(/'
,"*<3$"',@,("&'B.$(%*,I'*"B"**347'(%'(/"'
,(*)$()*"'%B'(/"'/".#(/$.*"',@,("&'.49'3(,'
#34?'(%'(/"',%$3%=2%#3(3$.#'&.$*%="$%4%&@'
34'>/3$/'3('%2"*.(",:'C/"'.9<.4(.7"'%B'
,%$3%=1"/.<3%)*.#'&%9"#,'3,'(/"'<.*3"(@'
%B'B.$(%*,I'%*7.43,"9'34(%'$.("7%*3",I'
(/.('&.?"'34("*<"4(3%4,'B%*'(/"*.2")(3$'
.$(3%4'l%*'#.$?'%B'3(m'B".,31#":'6('2"*&3(,'(/"'
",(.1#3,/&"4('%B'$%**"#.(3%4,'>3(/'7%%9'
2*"93$(.13#3(@I'1)('4%(',2"$3+$.(3%4'%B'
/%>'.49'>/@'(/"'93BB"*"4('B.$(%*,'.BB"$('
(/"*.2")(3$',"#"$(3%4:
Behavioural
attitude
Subjective
norms
Perceived
behavioural
control
Intention Behaviour
Figure 2 Theory of Planned Behaviour
17. Vodafone mHealth Solutions 18
Vodafone mHealth Solutions Insights Guide
Social Cognitive Theory
P*%&'(/"'ep_b,'%4>.*9,I'W.49)*.b'
has
9"<"#%2"9',%$3.#'$%743(3<"'(/"%*@'(%'
"D2#.34'/%>'2"%2#"'.$Q)3*"'.49'&.34(.34'
$"*(.34'1"/.<3%)*.#'2.(("*4,:'W.,"9'%4'
(/"'".*#3"*'C/"%*@'%B'J%$3.#'f".*4347e'
(/*""'9%&34.4('B.$(%*,'>"*"',""4'(%'
1"'$%4,(.4(#@'34i)"4$347'".$/'%(/"*L'
"4<3*%4&"4('l,%$3.#'.49'2/@,3$.#mI'
2"%2#"'.49'1"/.<3%)*:'
Bandura suggested that individuals are
$.2.1#"'%B'#".*4347'4%('Y),('B*%&'(/"3*'%>4'
"D2"*3"4$",I'1)('<3$.*3%),#@I'B*%&'(/%,"'
.*%)49'(/"&:'[4%>4'.,';1,"*<.(3%4.#'
f".*4347I'(/"'2*%$",,'3,'*"7)#.("9'1@'B%)*'
,)1'B)4$(3%4,L'
N'.(("4(3%4.#'2*%$",,",'
N'*"("4(3%4'2*%$",,",'
N'2*%9)$(3%4'2*%$",,",'
N'&%(3<.(3%4.#'2*%$",,",'
f34?"9'(%'(/3,'3,',"#B="B+$.$@'l1"/.<3%)*.#'
$.2.13#3(@mI'(/"'Z1"#3"B,'34'%4"E,'$.2.13#3(3",'
(%'%*7.43,"'.49'"D"$)("'(/"'$%)*,",'
%B'.$(3%4'*"Q)3*"9'(%'2*%9)$"'73<"4'
.((.34&"4(,E
:'J%$3.#'U%743(3<"'C/"%*@'
3,'),"9'"D("4,3<"#@'34'(/"'9",374'%B'
/".#(/'"9)$.(3%4'.49'/".#(/'1"/.<3%)*'
2*%7*.&&",'.49'.,'(/"'1.,3,'B%*'
intervention strategies.
Other theoretical considerations
[#"34&.4E,'$%4$"2('%B'KD2#.4.(%*@'
X%9"#,c
'$%4(.34'"D2#.4.(3%4,'%B'."(3%#%7@I'
%4,"('%B',@&2(%&,I'2.(/%2/@,3%#%7@I'
$%)*,"'%B',3$?4",,'.49'(*".(&"4(I'(%'
"#.1%*.("'Z,2"$3+$',@,("&,'%B'?4%>#"97"'
and values centred in the different social
,"$(%*,'.49',)1=,"$(%*,'%B'(/"'/".#(/$.*"'
,@,("&E]
:'64'2%#3(3$.#="$%4%&3",'%B'
/".#(/I'B.$(%*,'$.("7%*3,347'.<.3#.13#3(@I'
.$$",,313#3(@I'.BB%*9.13#3(@'.49'.$$"2(.13#3(@'
still dominate.
X.4@'&%9"#,'.,,)&"'(/.('3493<39).#,'
"47.7"'34'.'*.(3%4.#'2*%$",,'%B'>"37/347'
(/"'1"4"+(,'.49'$%,(,'%B'1"/.<3%)*.#'
choices and select the course of action
>3(/'(/"'&%,('B.<%)*.1#"'$%,(=1"4"+('
*.(3%'l.,'34'(/"'-".#(/'W"#3"B'X%9"#I'(/"'
C/"%*@'%B'R#.44"9'W"/.<3%)*I'.49'(/"'
J%$3.#'U%743(3<"'C/"%*@mI'1)('.BB"$(3<"'
associations`
'/.<"'.#,%'1""4',/%>4'(%'
1"'34i)"4(3.#:'M4#3?"'(/","'Z$%4(34))&E'
(/"%*3",'l>/3$/'2#.$"'.4'3493<39).#'.#%47'
.'$%4(34))&'%B'.$(3%4'#3?"#3/%%9mI'Z,(.7"9E'
(/"%*3",I',)$/'.,'(/"'C*.4,(/"%*"(3$.#'
X%9"#'%B'W"/.<3%)*'U/.47"'l.#,%',""'
+7)*"'cm_
'/.<"'.*3,"4'B*%&'9%)1('(/.('
#34".*'&%9"#,'.*"'B)##@'$.2.1#"'%B'$.2()*347'
(/"'$%&2#"D'2*%$",,",'(/.(')49"*#3"'
9"$3,3%4,'(%'"47.7"'34'/".#(/'1"/.<3%)*,d
.
69".##@I'.,'-.),&.44=X)"#.'$%4$#)9",I'
Z.'$%4("D().#3,"9'.4.#@,3,'%B'/".#(/'
1"/.<3%)*,',/%)#9'l.m'1"'4"$",,.*3#@'
34("*93,$32#34.*@I'$%&134347'Z4.()*.#'
,$3"4$",E'>3(/'Z,%$3.#',$3"4$",E'.22*%.$/",O'
l1m'4%('B.3#'(%'$%4,39"*'(/.('(/"',()93"9'
Z$%4("D(,E'.*"'2.*('%B'.'/3,(%*3$.#'2*%$",,O'
l$m'$%&134"'Z&3$*%E'>3(/'Z&.$*%E'#"<"#,O'.49'
l9m'(*3.47)#.("'Q).#3(.(3<"'.49'Q).4(3(.(3<"'
34<",(37.(3%4'("$/43Q)",En
.
C%')49"*,(.49'1"/.<3%)*'.,,%$3.("9'>3(/'
(/"'.9%2(3%4'%B'("$/4%#%73",'%B'/".#(/I'
>"'4""9'(%'%<"*#.@'(/"%*3",'9"*3<"9'B*%&'
,%$3.#'.49'1"/.<3%)*.#',$3"4$"I'>3(/'
(/"%*3",'%B'),"*'"47.7"&"4('9*.>4'B*%&'
(/"'+"#9,'%B'64B%*&.(3%4'U%&&)43$.(3%4'
.49'C"$/4%#%7@:
Stage 4: ACTION
Dedicates considerable
time and energy; make
overt and viable changes;
developes strategies to
deal with barriers
Stage 3:
PREPARATION
Intends to take action
and makes small changes;
needs to set goals
and priorities
Stage 2:
CONTEMPLATION
Aware the problem exists
and serious evaluation
of options but not
committed to
take action
Stage 1:
No intention to
change, often unaware
of the problem
Stage 6:
EVALUATION
Assessment and feedback
to continue dynamic
change process
Stage 5:
ADAPTATION /
MAINTENANCE
Works to adapt and adjust
to facilitate maintenance
of change
PRE-CONTEMPLATION
Figure 3 Transtheoretical Model of Behaviour Change
18. Vodafone mHealth Solutions 19
Vodafone mHealth Solutions Insights Guide
Diffusion of Innovations Theory
V%7"*,E'03BB),3%4'%B'644%<.(3%4,'
C/"%*@'l.#,%',""'+7)*"']mp
is the most
34i)"4(3.#'34')49"*,(.49347'/%>'.4'
344%<.(3%4'34+#(*.(",'.'2%2)#.(3%4'l%*'4%(mI'
.49'2*%<39",'.'$%&2*"/"4,3<"',(*)$()*"'
B%*')49"*,(.49347'3493<39).#'.9%2(3%4'.49I'
$%##"$(3<"#@I'93BB),3%4:'6('B%$),",'%4'(/"'
conditions that increase or decrease the
#3?"#3/%%9'%B'.'4">'39".I'2*%9)$('%*'
2*.$(3$"'1"347'.9%2("9:'
V%7"*,'2*","4("9'B%)*',(.7",L'
(/"'344%<.(3%4'3(,"#BO'93BB),3%4'l%*'
$%&&)43$.(3%4m'(/*%)7/'(/"',%$3.#',@,("&O'
(3&"O'.49'$%4,"Q)"4$",:'-"'.*7)"9'(/.('
.4'344%<.(3%4'3,'Z.4'39".I'2*.$(3$"I'%*'%1Y"$('
(/.('3,'2"*$"3<"9'(%'1"'4">'1@'.4'3493<39).#'
%*'%(/"*')43('%B'.9%2(3%4EI'93BB),3%4'3,'
Z(/"'Z2*%$",,'1@'>/3$/'.4'344%<.(3%4'3,'
communicated through certain channels
%<"*'.'2"*3%9'%B'(3&"'.&%47'(/"'&"&1"*,'
%B'.',%$3.#',@,("&EI'.49'$%&&)43$.(3%4'3,'
Z(/"'2*%$",,'34'>/3$/'2.*(3$32.4(,'$*".("'
.49',/.*"'34B%*&.(3%4'>3(/'%4"'.4%(/"*'
(%'*".$/'.'&)().#')49"*,(.49347E:'
C/"'(/"%*@',)77",(,'(/.('1"$.),"'
34B%*&.(3%4'i%>,'(/*%)7/'4"(>%*?,I'
%2343%4'#".9"*,'34'(/.('4"(>%*?'2#.@'.'
*%#"'34'9"("*&34347'(/"'#3?"#3/%%9'(/.('
(/"'344%<.(3%4'>3##'1"'.9%2("9I'1)('
.993(3%4.#'34("*&"93.*3",'l$/.47"'.7"4(,'
.49'7.("?""2"*,m'.*"'.#,%'34i)"4(3.#:'
P3<"'$.("7%*3",'%B'.9%2("*'.*"'%)(#34"9'
>/3$/'B%##%>'.4'J=,/.2"9'93BB),3%4'$)*<"L'
344%<.(%*,I'".*#@'.9%2("*,I'".*#@'&.Y%*3(@I'
#.("'&.Y%*3(@I'.49'#.77.*9,:'
03BB),3%4'*",".*$/'/.,'B%$),"9'%4'+<"'
&.34'"#"&"4(,L'(/"'$/.*.$("*3,(3$,'%B'
.4'344%<.(3%4'>/3$/'&.@'34i)"4$"'3(,'
.9%2(3%4O'(/"'9"$3,3%4=&.?347'2*%$",,'
(/.('%$$)*,'>/"4'3493<39).#,'$%4,39"*'
(/"'.9%2(3%4O'(/"'$/.*.$("*3,(3$,'%B'
3493<39).#,'(/.('&.?"'(/"&'#3?"#@'(%'.9%2('
.4'344%<.(3%4O'(/"'$%4,"Q)"4$",'B%*'
3493<39).#,'.49',%$3"(@'%B'.9%2(347'(/"'
344%<.(3%4O'.49'$%&&)43$.(3%4'$/.44"#,'
),"9'34'(/"'.9%2(3%4'2*%$",,:'U#%,"#@'
#34?"9'(%'03BB),3%4'%B'644%<.(3%4,'C/"%*@'
3,'G"(>%*?'F4.#@,3,'.49'J%$3.#'G"(>%*?'
C/"%*@cb
'.49'U*3(3$.#'X.,,'C/"%*@31
.
0
100
75
50
25
Marketshare%
Innovators
2.5%
Early
Adopters
13.5%
Early
Majority
34%
Late
Majority
34%
Laggards
16%
Figure 4 Diffusion of Innovations Theory
X.*?"('2"4"(*.(3%4
f"<"#'%B'.9%2(3%4
19. ''H%9.B%4"'&-".#(/'J%#)(3%4,''b
Vodafone mHealth Solutions Insights Guide
Technology Acceptance Model
C/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'3,'
%4"'%B'(/"'&%,('34i)"4(3.#'"D("4,3%4,'
%B'FYA"4E,'C/"%*@'%B'V".,%4"9'F$(3%4'.49'
C/"%*@'%B'R#.44"9'W"/.<3%)*:'0"<"#%2"9'1@'
0.<3,cI'cc
'3('3,'.4'34B%*&.(3%4',@,("&,'(/"%*@'
(/.('&%9"#,'/%>'),"*,'$%&"'(%'.$$"2('.49'
),"'.'("$/4%#%7@:'6('*"2#.$",'FYA"4E,'.((3()9"'
&".,)*",'>3(/'(>%'("$/4%#%7@'.$$"2(.4$"'
&".,)*",L'2"*$"3<"9'),"B)#4",,'l(/"'9"7*""'
(%'>/3$/'.'2"*,%4'1"#3"<",'(/.('),347'.'
2.*(3$)#.*',@,("&'>%)#9'"4/.4$"'/3,'%*'/"*'
Y%1'2"*B%*&.4$"mI'.49'2"*$"3<"9'".,"=%B=
),"'l(/"'9"7*""'(%'>/3$/'.'2"*,%4'1"#3"<",'
(/.('),347'.'2.*(3$)#.*',@,("&'>%)#9'1"'
B*""'B*%&'"BB%*(m:'C/"'&%9"#'.,,)&",'(/.('
>/"4',%&"%4"'B%*&,'.4'34("4(3%4'(%'.$(I'
(/"@'>3##'1"'B*""'(%'.$('>3(/%)('#3&3(.(3%4I'
>/"*".,'34'(/"'*".#'>%*#9I'(/"*"'>3##'1"'
<.*3%),'$%4,(*.34(,:';(/"*'&%9"#,'"D2#.34347'
.$$"2(.4$"'2"*$"2(3%4,'.49'1"/.<3%)*,'
.,,%$3.("9'>3(/'64B%*&.(3%4'C"$/4%#%7@'
34$#)9"'U%&2)("*'J"#B=KB+$.$@34
I'C.,?=
C"$/4%#%7@'P3(35
'.49'(/"'X%(3<.(3%4.#'
X%9"#36
.
United Theory of Acceptance and Use
'3.4"/5$'*'-6.7.8$%#"!.45"',6.'3.
Consumer Acceptance Technology
Recent studies have sought to integrate
,%&"'%B'(/"'2*3%*'&%9"#,:'H"4?.(",/37
"D.&34"9'"37/('%B'(/"'&%,('$%&&%4'
(/"%*"(3$.#'B*.&">%*?,'.49'&%9"#,'),"9'
(%'"D2#.34'3493<39).#'.9%2(3%4'.49'),"'%B'
("$/4%#%7@'.49'1*%)7/('(%7"(/"*'(/"3*'
&%,(',.#3"4('$/.*.$("*3,(3$,'(%'B%*&'.')43+"9'
(/"%*@I'M43("9'C/"%*@'%B'F$$"2(.4$"'.49'
M,"'%B'C"$/4%#%7@'l.#,%',""'+7)*"'`m:'
C/3,'2*","4(,'B%)*'?"@'9"("*&34.4(,'%B'),"'
l2"*B%*&.4$"'"D2"$(.4$@I'"BB%*('"D2"$(.4$@I'
,%$3.#'34i)"4$"'.49'B.$3#3(.(347'$%493(3%4,m'
and four moderators of individual use
l7"49"*I'.7"I'"D2"*3"4$"'.49'<%#)4(.*34",,m:'
J3&3#.*#@I'[)#<3>.(38
designed the Consumer
F$$"2(.4$"'%B'C"$/4%#%7@'B*.&">%*?'1@'
&"*7347'(>%'2*"<3%),#@')4*"#.("9'&%9"#,I'
(/"'C"$/4%#%7@'F$$"2(.4$"'X%9"#'.49'
(/"'R#".,)*"I'F*%),.#'.49'0%&34.4$"'
2.*.937&'%B'.BB"$('l9"<"#%2"9'.,'.'&%9"#'34'
"4<3*%4&"4(.#=2,@$/%#%7@'1@'X"/*.1.3439
I'
3(',)77",(,'(/.('.##'"&%(3%4.#'*",2%4,",'(%'
2/@,3$.#'.49',%$3.#'"4<3*%4&"4(,'$.4'1"'
$.2()*"9'>3(/'(/*""'93&"4,3%4,'%B'.BB"$(L'
2#".,)*"I'.*%),.#'.49'9%&34.4$"m:'
Sun and Zhang]b
'2*","4('.',@,("&.(3$'
.4.#@,3,'%B'(/"'"D2#.4.(%*@'.49',3().(3%4.#'
#3&3(.(3%4,'%B'"D3,(347'("$/4%#%7@'
.$$"2(.4$"',()93",:'C/"@'$.##'B%*'&%*"'
*",".*$/'34(%'(/"'3493<39).#'.49'$%4("D().#'
factors that are often neglected in
("$/4%#%7@'.$$"2(.4$"',()93",'1)('$.4'
1"'$*3(3$.#'34'(/"'.22#3$.(3%4'%B'(/"'
(/"%*"(3$.#'&%9"#,I'.49'39"4(3B@'("4'
&%9"*.(347'B.$(%*,'$%4,39"*"9'(%'1"'
34i)"4(3.#'l<%#)4(.*34",,I'(/"'4.()*"'%B'(.,?,'
.49'2*%B",,3%4,I'("$/4%#%73$.#'$%&2#"D3(@I'
(/"'2)*2%,"'%B'),347'("$/4%#%7@I'3493<39).#'
<,:'7*%)2'("$/4%#%73",I'7"49"*I'3493<39).#'
34("##"$().#'$.2.13#3(3",I'"D2"*3"4$"I'.7"'
.49'$)#()*.#'1.$?7*%)49m:
Adoption behaviours – barriers and
ways to overcome them
F,'(/"'+"#9'%B'&-".#(/'&.()*",I'%)*'
)49"*,(.49347'%B'.9%2(3%4'1"/.<3%)*,'
l1%(/'2%,3(3<"'.49'4"7.(3<"m'.,,%$3.("9'
>3(/'/".#(/'("$/4%#%7@')2(.?"'>3##'9"<"#%2'
34',$%2"'.49'4).4$":'C%'9.("I'*",".*$/'34'
(/3,'.*".'/.,'1""4'#3&3("9:'KD(*.2%#.("9'
B*%&'(/"'"D3,(347'#3("*.()*"I'(/"'B%##%>347'
1.**3"*,'(%')2(.?"',/%)#9'1"',""4'.,'.'
,(.*(347'2%34('B%*'B)()*"'>%*?:'F#(/%)7/'
&-".#(/'3,'%B("4'2%,3(3%4"9'%*'2"*$"3<"9'
.,'1"347'.'93,*)2(3<"'("$/4%#%7@'1@'
1%(/'/".#(/$.*"'2*%<39"*,'.49'*"$"3<"*,I'
34("*.$(3%4'%B("4'<.*3",'1"(>""4',(.?"/%#9"*'
7*%)2,:'!"'(/"*"B%*"'2*","4('(/"'9%&34.4('
1.**3"*,'B.$"9'1@'/".#(/$.*"'2*%<39"*,'
l1%(/'.,'3493<39).#,'.49'%*7.43,.(3%4,mI'
.49'(/%,"'B.$"9'1@'2.(3"4(,I'9",23("',%&"'
34"<3(.1#"'%<"*#.2:'!.@,'(%'%<"*$%&"'
(/","'1.**3"*,'.*"'(/"4',"('%)(:
J"<"*.#'Q)%(",'.*"'34$#)9"9'>/3$/'.*"'
.9.2("9'B*%&'(/"',(.?"/%#9"*'*",".*$/'
$%&&3,,3%4'1@'H%9.B%4"1
.
Figure 5 United Theory of Acceptance and Use of Technology
Performance
expectancy
Effort
expectancy
Social
influence
Facilitating
conditions
Behavioural
intention
Behaviour
Age
Experience
Gender
VoluntarinessofuseVoluntariness
Determinants
of use
Moderators of individual use